HALO X-ray Technologies has been spun out of the Imaging Science Group at Nottingham Trent University and the Cranfield Forensic Institute at Cranfield University. We are developing commercially-focused OEM X-ray diffraction solutions based on novel and patented Focal Construct Technology that provides platform capability across a wide range of application areas.
Our initial focus lies in the development of HALO solutions for the aviation security and the medical systems markets. We have strong ties to the aviation sector through a long and prestigious research and development programme that has previously realised novel divergent beam X-ray technology (developed and marketed through various incumbent suppliers such as 3DX-ray Ltd) and kinetic depth systems (developed and marketed through Astrophyscis Inc) as 3rd party solutions. We have a clear focus on medical systems and we are currently part of a consortium recentlly awarded an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. This is an exciting project and we look forward to working with our partners in developing HALO technology for this market.
Our development strategy focuses on the development of OEM products, which can be subsequently sold through a network of 3rd party suppliers across a wide range of applications areas.
Our initial focus lies in the development of HALO solutions for the aviation security and the medical systems markets. We have strong ties to the aviation sector through a long and prestigious research and development programme that has previously realised novel divergent beam X-ray technology (developed and marketed through various incumbent suppliers such as 3DX-ray Ltd) and kinetic depth systems (developed and marketed through Astrophyscis Inc) as 3rd party solutions. We have a clear focus on medical systems and we are currently part of a consortium recentlly awarded an EPSRC grant on Point-of-Care High Accuracy Fracture Risk Prediction. This is an exciting project and we look forward to working with our partners in developing HALO technology for this market.
Our development strategy focuses on the development of OEM products, which can be subsequently sold through a network of 3rd party suppliers across a wide range of applications areas.
Location: United Kingdom
Employees: 11-50
Founded date: 2012
Investors 1
| Date | Name | Website |
| - | BioCity | biocity.co... |
Mentions in press and media 3
| Date | Title | Description |
| 21.07.2026 | HALO X-ray Technologies Closes Funding | HALO X-ray Technologies (HALO), a Nottingham, UK-based X-ray detection technology company, raised an undisclosed amount in funding. The round was led by Agilent Technologies Inc, with both UKI2S and MEIF following their previous investments... |
| 20.07.2026 | HALO X-Ray Technologies Raises Multimillion-Dollar Funding To Advance Security Screening Platform | HALO X-ray Technologies has completed a multimillion-dollar funding round led by Agilent Technologies. Existing investors, UK Innovation Science Seed Fund and the Midlands Engine Investment Fund, also participated. The financing will help H... |
| 20.07.2026 | Agilent Increases Its Investment in HALO X-ray Technologies | HALO X-ray Technologies (HALO), the pioneering X-ray detection technology company, today announces that it has completed a funding round led by Agilent Technologies Inc, with both UKI2S and MEIF following their previous investments. This pr... |